Difficulty: Medium
Average Score: 70%
Practice
A medical student is involved in a summer research project evaluating the potencies of the α-adrenergic agonists at different receptor sites. Which of the following α-adrenergic agonists would be expected to have the strongest potency at the α-receptor?
Correct answer
C
Rationale
The correct answer is C) Norepinephrine. Norepinephrine is expected to have the strongest potency at the ╬▒-receptor because it is a direct agonist that specifically acts on ╬▒-adrenergic receptors. Norepinephrine has a higher affinity for ╬▒-receptors compared to other options.
Option A, Acetylcholine, is a neurotransmitter that acts on cholinergic receptors, not ╬▒-adrenergic receptors. Option B, Epinephrine, while also an adrenergic agonist, has a higher affinity for ╬▓-adrenergic receptors rather than ╬▒-receptors. Option D, Metanephrine, is a metabolite of epinephrine and does not directly act on adrenergic receptors.
In an educational context, understanding the selectivity and potency of different adrenergic agonists is crucial in pharmacology. Knowing which agonist acts on which receptor subtype can help in predicting their physiological effects and clinical applications. This knowledge is essential for healthcare professionals when prescribing medications that target the adrenergic system to achieve specific therapeutic outcomes.
Option A, Acetylcholine, is a neurotransmitter that acts on cholinergic receptors, not ╬▒-adrenergic receptors. Option B, Epinephrine, while also an adrenergic agonist, has a higher affinity for ╬▓-adrenergic receptors rather than ╬▒-receptors. Option D, Metanephrine, is a metabolite of epinephrine and does not directly act on adrenergic receptors.
In an educational context, understanding the selectivity and potency of different adrenergic agonists is crucial in pharmacology. Knowing which agonist acts on which receptor subtype can help in predicting their physiological effects and clinical applications. This knowledge is essential for healthcare professionals when prescribing medications that target the adrenergic system to achieve specific therapeutic outcomes.